Is Peripheral Vascular Disease (PVD) essential for Pulmonary Vascular Resistance (PVR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PVD is NOT Essential for PVR

No, Peripheral Vascular Disease (PVD) is not essential for Pulmonary Vascular Resistance (PVR). These are distinct entities affecting different vascular beds—PVD refers to systemic arterial disease (typically atherosclerotic disease of peripheral arteries), while PVR is a hemodynamic measurement of resistance in the pulmonary circulation.

Understanding the Terminology Distinction

The confusion likely stems from the term "PVD" being used in different contexts:

  • Peripheral Vascular Disease (PVD): Refers to atherosclerotic disease affecting systemic arteries, particularly lower extremities 1, 2

  • Pulmonary Vascular Disease (PVD): A completely separate entity referring to pathologic changes in the pulmonary vasculature that can lead to elevated PVR 1

When discussing pulmonary hypertension, "PVD" in the literature refers to pulmonary vascular disease, not peripheral vascular disease. This is a critical distinction that prevents clinical confusion.

Pulmonary Vascular Disease and PVR Relationship

When PVD (Pulmonary) Causes Elevated PVR

Pulmonary vascular disease is characterized by structural and functional abnormalities of the pulmonary vasculature that directly increase PVR 1:

  • Decreased vascular growth: Reduced small pulmonary arteries and altered distribution within lung interstitium 1
  • Increased vascular tone and vasoreactivity: Hypertensive remodeling and abnormal vasoconstriction 1
  • Reduced alveolar-capillary surface area: Limits vascular recruitment and increases resistance 1

Clinical Contexts Where Pulmonary PVD Elevates PVR

In Bronchopulmonary Dysplasia (BPD): Abnormalities of lung circulation are "more broadly related to PVD resulting from decreased vascular growth, which also contributes to disease pathogenesis and abnormal cardiopulmonary physiology" 1. High PVR in BPD causes poor RV function, impaired cardiac output, limited oxygen delivery, and increased pulmonary edema 1.

In Congenital Heart Disease: The state of the pulmonary vascular bed strongly influences outcomes, as "small elevations of PVR can markedly impair cardiac performance" 1. Determination of baseline hemodynamics and PVR is crucial for surgical candidacy 1.

In Left Heart Disease: Pulmonary vascular disease in LHD is associated with combined post- and pre-capillary pulmonary hypertension (CpcPH), defined by PVR ≥3.0 Wood Units, and is linked to worse RV-PA uncoupling, greater ventricular interaction, and more severe impairments in cardiac output 3.

Elevated PVR Without Pulmonary Vascular Disease

PVR can be elevated without structural pulmonary vascular disease in conditions where:

  • Increased pulmonary blood flow occurs without vascular remodeling (high-flow states) 1
  • Elevated left atrial pressure causes passive pulmonary hypertension without fixed vascular changes (isolated post-capillary PH) 3
  • Acute vasoconstriction from hypoxia or acidosis transiently increases PVR 1

Clinical Implications

The distinction matters for treatment decisions: Patients with elevated PVR due to structural pulmonary vascular disease may require PAH-specific therapy and have different prognoses compared to those with elevated PVR from passive congestion alone 1, 3.

Cardiac catheterization is essential to distinguish between elevated PVR with and without pulmonary vascular disease, measuring transpulmonary gradient, PVRI, and assessing vasoreactivity 1.

Common pitfall: Assuming all elevated PVR represents fixed pulmonary vascular disease—acute vasodilator testing can identify reversible components 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evidence-based management of peripheral vascular disease.

Current atherosclerosis reports, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.